サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575010

インプラント周囲炎治療市場：製品タイプ別、治療タイプ別、作用機序別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Peri-Implantitis Treatment Market, By Product Type, By Treatment Type, By Mechanism of Action, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
インプラント周囲炎治療市場：製品タイプ別、治療タイプ別、作用機序別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

インプラント周囲炎治療市場規模は2023年に24億8,043万米ドルとなり、2024年から2032年にかけてCAGR 8.90%で拡大

インプラント周囲炎治療市場-市場力学

老人人口の増加がインプラント周囲炎治療市場の需要を促進

高齢者はインプラントの不具合を含む歯科合併症を起こしやすいため、高齢者人口の増加がインプラント周囲炎治療市場の需要を大きく押し上げています。世界保健機関（WHO）によると、60歳以上の世界人口は2050年までに20億人に達すると予測されており、効果的な歯科治療ソリューションに対するニーズが高まっています。さらに、インプラント周囲炎は、インプラント患者の10～20％近くが罹患しているという研究結果もあり、的を絞った治療の必要性が浮き彫りになっています。米国歯周病学会（American Academy of Periodontology）のような組織による取り組みは、予防と治療オプションに関するヘルスケア専門家の教育に重点を置いており、市場の成長をさらに促進しています。認知度の向上と先進的な治療法の採用により、インプラント周囲炎治療分野は、高齢化する人口の進化するニーズに対応できる体制を整えており、人口動向とヘルスケア革新の重要な交差点を浮き彫りにしています。

インプラント周囲炎治療市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.90%のCAGRで毎年成長すると推定されます。

製品タイプ別では、抗生物質が2023年に最大の市場シェアを示すと予測されます。

治療タイプ別では、非外科的治療が2023年の主要タイプでした。

作用機序別では、2023年には局所投与が主要タイプでした。

地域別では、北米が2023年の主要収益源であった

インプラント周囲炎治療市場-セグメンテーション分析：

世界のインプラント周囲炎治療市場は、製品タイプ、治療タイプ、作用機序、エンドユーザー、地域に基づいて区分されます。

市場は製品タイプに基づいて4つのカテゴリーに分けられる：すなわち、抗生物質、防腐剤、骨移植片、再生材料です。抗生物質は感染症の管理に有効であることから優先的に使用され、次いで微生物負荷の軽減に役立つ防腐剤が使用されます。骨移植片は骨の完全性の回復に重要な役割を果たし、再生材料は組織の治癒と再生をサポートします。

市場は治療タイプによって2つのカテゴリーに分けられる：非外科的治療と外科的治療です。非外科的治療は、低侵襲性で初期段階での有効性が優先される一方、外科的治療は、インプラントの健全性と機能を回復するためのより広範な介入を必要とする進行症例に不可欠です。

インプラント周囲炎治療市場-地理的洞察

インプラント周囲炎治療市場は、地域によって大きな違いが見られますが、北米はヘルスケアのインフラが整っており、インプラントの普及率も高いことから、主要な地域となっています。米国歯科医師会は、米国では約300万人がインプラント治療を受けており、インプラント周囲炎治療のニーズが高まっていると指摘しています。ドイツや英国などの国々では、インプラントの治療成績を向上させることを目的とした先進的な歯科技術や研究イニシアチブに投資しています。アジア太平洋では、急速な都市化と可処分所得の増加が歯科インプラントと関連治療の需要を牽引しており、タイやインドなどの国々ではデンタルツーリズムが顕著に増加しています。一方、中東やアフリカでは、ヘルスケアインフラの改善に向けた取り組みが行われ、歯科治療に対する認識やアクセシビリティが徐々に高まっています。世界の協力関係や調査が拡大するにつれて、インプラント周囲炎の治療状況は進化し、さまざまな地域で直面する独自の課題に対処しながら、世界中でより良い口腔衛生の実践が推進されるようになるでしょう。

インプラント周囲炎治療市場-競合情勢：

インプラント周囲炎治療市場の競合情勢では、革新的な治療ソリューションの最前線に立つZimmer Biomet社やDentsply Sirona社などの主要企業が牽引する北米が、支配的な地域として際立っています。米国歯周病学会（American Academy of Periodontology）は、歯科インプラント患者の約10％から20％がインプラント周囲炎を経験すると報告しており、先進治療の成長に拍車をかけています。欧州では、Straumann社やBioHorizons社などの主要企業が、治療効果を高めるための厳密な臨床研究に支えられ、牽引役となっています。アジア太平洋では、口腔の健康に対する意識の高まりと歯科インプラントの普及が市場の成長を促進しており、Osstem Implantのような地域企業が牽引役となっています。中東・アフリカでは、歯科ヘルスケアへの投資が増加しており、質の高いインプラント周囲炎治療へのアクセス改善に重点を置いた地域的な取り組みが行われています。競合情勢の全体的な特徴として、既存の企業と新興企業が混在しており、いずれも効果的なインプラント周囲炎管理ソリューションに対する世界の需要の増加に対応しようと努力しています。

目次

第1章 インプラント周囲炎治療市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 インプラント周囲炎治療の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 インプラント周囲炎治療産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 インプラント周囲炎治療市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 インプラント周囲炎治療市場情勢

  • インプラント周囲炎治療市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 インプラント周囲炎治療市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 抗生物質
    • 防腐剤
    • 骨移植
    • 再生材料

第8章 インプラント周囲炎治療市場-治療タイプ別

  • 概要
    • 治療タイプ別セグメントシェア分析
    • 非外科的治療
    • 外科的治療

第9章 インプラント周囲炎治療市場- 作用機序別

  • 概要
    • 作用機序別セグメントシェア分析
    • 局所的投与
    • 全身投与

第10章 インプラント周囲炎治療市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 歯科医院
    • 病院
    • 研究機関

第11章 インプラント周囲炎治療市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- インプラント周囲炎治療業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Bicon, LLC
    • BioHorizons IPH, Inc.
    • Camlog Biotechnologies AG
    • Corus Medical, Inc.
    • Dentium Co., Ltd.
    • Dentsply Sirona Inc.
    • Henry Schein, Inc.
    • Hiossen, Inc.
    • Implant Direct Sybron International
    • Keystone Dental, Inc.
    • Megagen Implant Co., Ltd.
    • Nobel Biocare Services AG
    • Osstem Implant Co., Ltd.
    • Straumann Holding AG
    • TBR Implants
    • Zimmer Biomet Holdings, Inc.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV4005

REPORT HIGHLIGHT

Peri-Implantitis Treatment Market size was valued at USD 2,480.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The peri-implantitis treatment market focuses on addressing inflammation and bone loss around dental implants, affecting a significant portion of the population, with studies indicating that up to 30% of implant patients experience peri-implantitis at some point. Factors such as the increasing prevalence of dental implants, the rising geriatric population, and advancements in dental technologies are propelling market growth. However, challenges such as high treatment costs and limited patient awareness may restrain market expansion. Opportunities lie in the development of innovative treatment modalities, such as laser therapy and biomaterials for enhanced healing. Additionally, educational initiatives aimed at dental professionals and patients can further drive awareness and treatment adoption, ensuring better outcomes for those affected by this condition. Organizations like the American Academy of Periodontology emphasize the importance of peri-implant health, further supporting the need for effective treatment solutions.

Peri-Implantitis Treatment Market- Market Dynamics

Increasing Geriatric Population Fuels Demand in the Peri-Implantitis Treatment Market

The rising geriatric population is significantly boosting demand in the peri-implantitis treatment market, as older adults are more prone to dental complications, including implant failures. According to the World Health Organization, the global population aged 60 and older is projected to reach 2 billion by 2050, leading to a heightened need for effective dental care solutions. Moreover, studies have shown that peri-implantitis affects nearly 10-20% of implant patients, underscoring the necessity for targeted treatments. Initiatives from organizations like the American Academy of Periodontology are focusing on educating healthcare professionals about prevention and treatment options, further driving market growth. With increasing awareness and the adoption of advanced therapeutic methods, the peri-implantitis treatment sector is well-positioned to meet the evolving needs of an aging population, highlighting the critical intersection of demographic trends and healthcare innovation.

Peri-Implantitis Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on product type segmentation, antibiotics were predicted to show maximum market share in the year 2023

Based on Treatment Type segmentation, Non-Surgical Treatments was the leading type in 2023

Based on Mechanism of Action segmentation, Localized Delivery was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Peri-Implantitis Treatment Market- Segmentation Analysis:

The Global Peri-Implantitis Treatment Market is segmented on the basis of Product Type, Treatment Type, Mechanism of Action, End-User, and Region.

The market is divided into four categories based on product type: Antibiotics, Antiseptics, Bone Grafts, and Regenerative Materials. Antibiotics are prioritized due to their effectiveness in managing infections, followed by antiseptics that help in reducing microbial load. Bone grafts play a crucial role in restoring bone integrity, while regenerative materials support tissue healing and regeneration.

The market is divided into two categories based on Treatment Type: Non-Surgical Treatments and Surgical Treatments. Non-surgical treatments are prioritized for their minimally invasive nature and effectiveness in early stages, while surgical treatments are essential for advanced cases requiring more extensive intervention to restore implant health and function.

Peri-Implantitis Treatment Market- Geographical Insights

The peri-implantitis treatment market exhibits significant regional variations, with North America emerging as a leading region due to its advanced healthcare infrastructure and high adoption rates of dental implants. The American Dental Association highlights that nearly 3 million people in the U.S. have dental implants, increasing the need for peri-implantitis treatments. Europe follows closely, where countries like Germany and the UK invest in advanced dental technologies and research initiatives aimed at improving implant outcomes. In Asia-Pacific, rapid urbanization and rising disposable incomes are driving the demand for dental implants and associated treatments, with a notable increase in dental tourism in countries like Thailand and India. Meanwhile, the Middle East and Africa are gradually increasing awareness and accessibility to dental care, as initiatives focus on improving healthcare infrastructure. As global collaborations and research expand, the treatment landscape for peri-implantitis is set to evolve, addressing the unique challenges faced in different regions while promoting better oral health practices worldwide.

Peri-Implantitis Treatment Market- Competitive Landscape:

In the competitive landscape of the peri-implantitis treatment market, North America stands out as a dominant region, driven by key players such as Zimmer Biomet and Dentsply Sirona, who are at the forefront of innovative treatment solutions. The American Academy of Periodontology has reported that approximately 10% to 20% of dental implant patients experience peri-implantitis, spurring growth in advanced therapies. Europe follows closely, with companies like Straumann and BioHorizons leading the charge, supported by rigorous clinical studies to enhance treatment efficacy. In Asia-Pacific, growing awareness of oral health and increasing dental implant adoption are fostering market growth, with regional players like Osstem Implant gaining traction. The Middle East and Africa are witnessing a rise in dental healthcare investments, with local initiatives focusing on improving access to quality peri-implantitis treatments. Overall, the competitive landscape is characterized by a mix of established players and emerging companies, all striving to address the increasing demand for effective peri-implantitis management solutions globally.

Recent Developments:

In November 2023, UCLA researchers developed a groundbreaking UV light technology to combat peri-implantitis, significantly enhancing osseointegration and reducing complications. The one-minute UV treatment removes hydrocarbons from titanium implants, promoting faster healing and limiting bacterial invasion, aiming to eradicate peri-implantitis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bicon, LLC
  • BioHorizons IPH, Inc.
  • Camlog Biotechnologies AG
  • Corus Medical, Inc.
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Henry Schein, Inc.
  • Hiossen, Inc.
  • Implant Direct Sybron International
  • Keystone Dental, Inc.
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • Straumann Holding AG
  • TBR Implants
  • Zimmer Biomet Holdings, Inc.
  • Others

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Antibiotics
  • Antiseptics
  • Bone Grafts
  • Regenerative Materials

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Surgical Treatments
  • Surgical Treatments

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY MECHANISM OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Localized Delivery
  • Systemic Delivery

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Dental Clinics
  • Hospitals
  • Research Laboratories

GLOBAL PERI-IMPLANTITIS TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Peri-Implantitis Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Peri-Implantitis Treatment Market Snippet by Product Type
    • 2.1.2. Peri-Implantitis Treatment Market Snippet by Treatment Type
    • 2.1.3. Peri-Implantitis Treatment Market Snippet by Mechanism of Action
    • 2.1.4. Peri-Implantitis Treatment Market Snippet by End-User
    • 2.1.5. Peri-Implantitis Treatment Market Snippet by Country
    • 2.1.6. Peri-Implantitis Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Peri-Implantitis Treatment Key Market Trends

  • 3.1. Peri-Implantitis Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Peri-Implantitis Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Peri-Implantitis Treatment Market Opportunities
  • 3.4. Peri-Implantitis Treatment Market Future Trends

4. Peri-Implantitis Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Peri-Implantitis Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Peri-Implantitis Treatment Market Landscape

  • 6.1. Peri-Implantitis Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Peri-Implantitis Treatment Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Antibiotics
    • 7.1.3. Antiseptics
    • 7.1.4. Bone Grafts
    • 7.1.5. Regenerative Materials

8. Peri-Implantitis Treatment Market - By Treatment Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Type, 2023 & 2032 (%)
    • 8.1.2. Non-Surgical Treatments
    • 8.1.3. Surgical Treatments

9. Peri-Implantitis Treatment Market - By Mechanism of Action

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Mechanism of Action, 2023 & 2032 (%)
    • 9.1.2. Localized Delivery
    • 9.1.3. Systemic Delivery

10. Peri-Implantitis Treatment Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Dental Clinics
    • 10.1.3. Hospitals
    • 10.1.4. Research Laboratories

11. Peri-Implantitis Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Peri-Implantitis Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Peri-Implantitis Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Peri-Implantitis Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Peri-Implantitis Treatment Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Peri-Implantitis Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Mechanism of Action, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Peri-Implantitis Treatment Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Bicon, LLC
    • 12.2.2. BioHorizons IPH, Inc.
    • 12.2.3. Camlog Biotechnologies AG
    • 12.2.4. Corus Medical, Inc.
    • 12.2.5. Dentium Co., Ltd.
    • 12.2.6. Dentsply Sirona Inc.
    • 12.2.7. Henry Schein, Inc.
    • 12.2.8. Hiossen, Inc.
    • 12.2.9. Implant Direct Sybron International
    • 12.2.10. Keystone Dental, Inc.
    • 12.2.11. Megagen Implant Co., Ltd.
    • 12.2.12. Nobel Biocare Services AG
    • 12.2.13. Osstem Implant Co., Ltd.
    • 12.2.14. Straumann Holding AG
    • 12.2.15. TBR Implants
    • 12.2.16. Zimmer Biomet Holdings, Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us